Does Red Light Therapy Actually Work? 3 Studies, 3 Very Different Answers
The Energy Code
Final Thesis: Context Matters
Mike summarizes that PBM is real but context-, dose-, and endpoint-dependent; asks about creating protocol map.
Photobiomodulation (PBM) and low-level light therapy (LLLT) are everywhere, and so are the claims: more ATP, better recovery, fat loss, nervous system balance, strength gains… all from the same “red light” buzzword.
In this 3-paper masterclass, Dr. Mike Belkowski breaks the hype down into evidence, endpoints, and bottlenecks. You’ll get a clean, practical analysis of three very different PBM applications:
-
Body circumference reduction (systematic review of sham-controlled RCTs)
-
Autonomic nervous system regulation using HRV after infra-auricular/vagus-region PBM (randomized controlled trial)
-
Upper-body performance on a real-world compound lift (bench press) in collegiate athletes (double-blind repeated-measures)
Then we connect the dots: why PBM can show a strong signal in one domain, a weak signal in another, and no signal at all when the limiting factor isn’t mitochondrial energy; but coordination, sleep, stress, or recovery terrain.
Bottom line: light is real, but its application is not universal — it works when the tool matches the job.
(Educational content only, not medical advice.)
-
Articles Discussed in Episode:
The influence of photobiomodulation on upper body muscular performance in collegiate athletes
Low-level laser therapy for reducing body circumferences: a systematic review
-
Key Quotes From Dr. Mike:
“The PBM trap is thinking ‘more ATP’ automatically means better everything.”
“Light therapy is real, but real does not mean universal. It means context-dependent.”
“HRV is a moving target — sleep, caffeine, hydration, stress can drown out small effects.”
“If you want nervous system balance, the big levers are still sleep, rhythm, breath, and training load.”
“Ask better questions: what tissue, what depth, what dose, what endpoint?”
-
Key points
-
PBM is a signal, not a guarantee → Match the tool to the job.
-
Paper 1 (LLLT body contouring): short-term circumference reductions beat sham; high satisfaction; good tolerability; only 3 RCTs → promising but early.
-
Devices/wavelengths varied (e.g., 532 nm, 635 nm, 635–680 nm) → can’t yet define “best protocol.”
-
Follow-up windows were short (weeks) → durability still unknown long-term.
-
Mechanism proposed: adipocyte emptying/pores (adipocytolysis / lipid peroxidation) more than guaranteed fat-cell death → lifestyle may determine persistence.
-
Paper 2 (HRV/vagus-region PBM): acute 660 nm infraauricular PBM showed minimal HRV changes in healthy active adults; one entropy metric differed.
-
HRV is a noisy systems output influenced by many variables; acute PBM may be underdosed or target too indirect.
-
Paper 3 (bench press): PBM did not beat sham for 1RM, volume load, or soreness; baseline-to-week improvement likely learning/familiarization, not light.
-
As movement complexity increases, PBM’s effect may drop if the limiter is coordination/neural drive, not local muscle energetics.
-
Core takeaway: PBM efficacy is bottleneck-dependent—hit the bottleneck, see signal; miss it, see nothing.
-
Episode timeline
-
0:02–1:58 Setup: PBM isn’t magic—3 papers, 3 targets, 3 outcomes
-
1:59–14:48 Paper 1: LLLT body circumference systematic review (signal + limits)
-
15:19–21:47 Paper 2: Vagus-region PBM + HRV trial (mostly null; why that matters)
-
22:15–28:57 Paper 3: Bench press performance trial (PBM vs sham; no advantage)
-
29:01–35:19 Compare/contrast: endpoints, bottlenecks, evidence strength, mechanism chain length
-
35:38–37:23 Practical decision framework by goal (contouring vs HRV vs compound strength)
-
37:31–39:55 Final thesis: PBM works sometimes — context, dose, and bottleneck decide
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight:
The AI-powered Podcast Player
